This study is an open-label, randomized, 2 parallel group, single dose study in healthy
Japanese males to assess the pharmacokinetics and safety/tolerability of single intravenous
administration and single subcutaneous administration of GSK1550188. Serial blood samples for
the determination of GSK1550188 concentration will be collected and safety assessments will
be performed for each treatment group